Skip to main content
OpenTrials
Completed

NCT Number: NCT05875779

Peer Education as a Strategy to Promote Vaccine Acceptance

Effective interventions to improve uptake of vaccines among hesitant groups are urgently needed. Peer education is an effective intervention in modifying health behaviors in other conditions and may be effective in promoting vaccine confidence but has not been studied. To fill this knowledge gap, we will enroll approximately 152 parents of children age 0-18 months who are eligible for pneumococcal conjugate (PCV-13) vaccine and randomize them 1:1 to a peer-led vaccine education intervention or usual care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vaccine Acceptance

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NYU Grossman School of Medicine, Division of Infectious Diseases

New York, 10016, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A parent of a child aged 0 to 18 months born at ≥35 weeks' gestation who is eligible for a dose of PCV-13. Eligibility by age defined as follows:
  • Age 0-6 months: never received first dose or is >8 weeks from last dose (3 doses scheduled in this age group at 2, 4, and 6 months)
  • Age 7-11 months: never received first dose or is > 8 weeks from last dose (2 doses scheduled in this age group if started at 7 months)
  • 12-18 months: never received first dose, is >8 weeks from last dose (2 doses scheduled in this age group if started at 12 months) or is due for booster at 12-18 months having received primary series between age 2-11 months.
  • Self-identifies as Orthodox Jewish.
  • Is able to provide informed consent.

Exclusion criteria

  • Unable to communicate verbally in English or Yiddish
  • Unwilling or unable to utilize a Yiddish in-person or telephone interpreter
  • Has already participated in this study as an eligible adult or parent. A parent will only be able to participate in this study once (i.e. for only one child in the family that is eligible)
  • Has an appointment at clinic that day to specifically receive vaccines.

Treatment and study plan

Peer-led vaccine education intervention

Behavioral

The intervention will be delivered face-to-face by a trained peer-educator and will consist of one session of 10-20 minutes.

Peer vaccine educators will receive written vaccine materials for distribution. These materials will present content that accurately represents the risks and benefits of vaccination.

Responsibilities of the vaccine educators will be to: provide motivational interviewing with patients, provide vaccine counseling, address questions and concerns regarding available vaccines, brief clinical provider on hesitant patients and areas of their vaccine-related concerns, and provide follow-up with participants at day 30, day 60 and day 90 for additional engagement.

Primary outcomes

  1. Number of Participants Ages 0 Months to 18 Months at Enrollment who Receive at least One Dose of PCV-13 Vaccine by 3 Months Post-Enrollment

    Time frame: Month 3 Post-Enrollment

    Outcome will be determined via review of patient medical chart.

Secondary outcomes

  1. Number of Participants Ages 1 Month to 18 Months at Enrollment who Receive at least One Dose of PCV-13 Vaccine by 1 Month Post-Enrollment

    Time frame: Month 1 Post-Enrollment

    Outcome will be determined via review of patient medical chart.

  2. Percentage of Days Under-immunized at 3 Months among Participants Ages 0 Months to 18 Months at Enrollment

    Time frame: Month 1 Post-Enrollment

    To obtain the percentage of days underimmunized, investigators will sum the days late across all 4 doses of PCV-13 doses and will divide this by the maximum cumulative number of days a child could be late if they had received no vaccine doses by their age one month post study enrollment. If a dose was never received, the maximum number of days late a child could be for dose will be: age at enrollment in days+31 days minus the latest age in days in which that dose should have been received.

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Official study title

Developing Vaccine Educators Within Practices of Community Healthcare Providers: a Pragmatic, Randomized Controlled Trial of Peer Education to Promote Vaccine Acceptance

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
May 25, 2023
Registry last updated
Aug 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.